[Form 4] Horace Mann Educators Corporation Insider Trading Activity

Rhea-AI Filing Summary

Marita Zuraitis, President & CEO and director of Horace Mann Educators Corp (HMN), reported a sale of 5,000 shares of Common Stock on 09/02/2025 at a price of $45.76 per share. The filing states the sale was made pursuant to a Rule 10b5-1 trading plan adopted on 11/18/2024. After the reported disposition, the reporting person beneficially owns 297,154.72 shares, which the filing explains comprises 210,840.720 vested restricted stock units and 86,314 shares of Common Stock. The Form 4 was signed by an attorney-in-fact on 09/04/2025.

Positive

• Sale executed under a Rule 10b5-1 trading plan, indicating pre-established compliance procedures
• Clear disclosure of remaining beneficial ownership including vested RSUs and shares

Negative

• Insider sale of 5,000 shares which modestly reduces the CEO's direct holdings
• Form 4 does not disclose any future changes to trading plans or additional transactions

Insights

Corporate Governance Expert

TL;DR: Routine insider sale under a pre-established 10b5-1 plan; shows compliance but reduces insider's direct equity slightly.

The sale of 5,000 shares executed under a Rule 10b5-1 plan signals a pre-authorized, systematic disposition rather than ad-hoc trading. That supports governance and compliance processes, as trades under documented plans help mitigate concerns about trading on material nonpublic information. The remaining beneficial ownership disclosed—210,840.720 vested RSUs plus 86,314 shares—provides clear disclosure of currently vested economic exposure. This Form 4 contains no information about planned future sales or changes to compensation arrangements.

Securities Analyst

TL;DR: The transaction is small relative to total holdings and was executed at $45.76 per share under an existing plan; impact on valuation is likely minimal.

The reported sale of 5,000 shares at $45.76 is a limited disposition compared with the total reported beneficial ownership of 297,154.72 shares. Because the sale occurred under a 10b5-1 plan adopted in November 2024, it is likely a pre-scheduled transaction rather than a market signal from contemporaneous company developments. The filing does not disclose any derivative activity or changes to outstanding option positions. No material change to control or board composition is indicated.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ZURAITIS MARITA

(Last) (First) (Middle)

1 HORACE MANN PLAZA

(Street)

SPRINGFIELD IL 62715

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HORACE MANN EDUCATORS CORP /DE/ [ HMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	09/02/2025		S		5,000	D	$45.76	297,154.72(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2024.

2. Represents 210,840.720 vested restricted stock units and 86,314 shares of Common Stock.

Remarks:

	Linea K. Michael, Attorney in Fact for Marita Zuraitis	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did HMN insider Marita Zuraitis sell on 09/02/2025?

She sold 5,000 shares of Horace Mann (HMN) common stock at $45.76 per share.

Was the sale by Marita Zuraitis part of a prearranged plan?

Yes. The sale was effected under a Rule 10b5-1 trading plan adopted on 11/18/2024.

How many shares does Marita Zuraitis beneficially own after the sale?

The filing reports beneficial ownership of 297,154.72 shares, comprising 210,840.720 vested RSUs and 86,314 shares.

Did the Form 4 report any derivative transactions for Marita Zuraitis?

No. Table II for derivative securities shows no reported transactions in this filing.

Who signed the Form 4 filing for Marita Zuraitis?

The Form 4 was signed by Linea K. Michael, Attorney in Fact for Marita Zuraitis on 09/04/2025.